5‐AZACYTIDINE TREATMENT IN A βo‐THALASSAEMIC PATIENT UNABLE TO BE TRANSFUSED DUE TO MULTIPLE ALLOANTIBODIES
- 1 July 1989
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 72 (3), 467
- https://doi.org/10.1111/j.1365-2141.1989.tb07734.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacological Manipulation of Fetal Hemoglobin Synthesis in Patients with Severe β‐ThalassemiaAnnals of the New York Academy of Sciences, 1985
- 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemiaBlood, 1983
- 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemiaBlood, 1983
- 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+ThalassemiaNew England Journal of Medicine, 1982
- Transfusion Reaction During Marrow Suppression in a Thalassemic Patient with a Blood Group Anomaly and an Unusual Cold AgglutininVox Sanguinis, 1965
- Observations on the Foam Cell in ThalassemiaBlood, 1960